SEC Form D · filed June 25, 2019
BioEclipse Therapeutics, Inc
Location
SOUTH SAN FRANCISCO, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Gregory Schiffman · South San Francisco, CADirectorBenjamin Carter · South San Francisco, CAExecElona Baum · South San Francisco, CADirectorBiao He · South San Francisco, CADirectorStephen Thau · South San Francisco, CAExecMark Frohlich · South San Francisco, CADirectorCatherine Sohn · South San Francisco, CADirectorChris A. Santana · New York, NYDirectorStanton B. Shafer · Tucson, AZExecStacey-Ann A. Kirkconnell · GRAND CAYMAN, Cayman IslandsDirectorChristopher A. Day · BECKENHAM, United KingdomDirectorLani Baker · Tucson, AZExecColin Siew · SINGAPORE, U0DirectorTomofumi Oda · SINGAPORE, U0DirectorPamela Contag · South San Francisco, CAExec · DirectorMichael Augins · Scottsdale, AZDirectorRezwan Manji · Scottsdale, AZDirectorJohn Platts · Austin, TXDirectorRobert Habermeier · Austin, TXDirectorRobert J. Geary · Houston, TXDirectorChad M. Tappendorf · NEW YORK, NYExecJ. F. Funnell · FAIRFAX, CAExecPamela Contag · South San Francisco, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗